A Time to Keep and a Time to Cast Away Categories of Tumor Response
- 10 August 2011
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (23) , 3109-3111
- https://doi.org/10.1200/jco.2011.36.3887
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Variability of Lung Tumor Measurements on Repeat Computed Tomography Scans Taken Within 15 MinutesJournal of Clinical Oncology, 2011
- On the Use of Change in Tumor Size to Predict Survival in Clinical Oncology Studies: Toward a New Paradigm to Design and Evaluate Phase II StudiesClinical Pharmacology & Therapeutics, 2009
- Elucidation of Relationship Between Tumor Size and Survival in Non-Small-Cell Lung Cancer Patients Can Aid Early Decision Making in Clinical Drug DevelopmentClinical Pharmacology & Therapeutics, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Model-based drug development applied to oncologyExpert Opinion on Drug Discovery, 2007
- Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2006
- Learning versus confirming in clinical drug development*Clinical Pharmacology & Therapeutics, 1997
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Reporting results of cancer treatmentCancer, 1981
- The effect of measuring error on the results of therapeutic trials in advanced cancerCancer, 1976